- High-dose intravenous immunoglobulins. As a consequence of the discovery of the anti-Fas potential of pooled human intravenous immunoglobulins (IVIG) in vitro [44], IVIG have been tested for the treatment of TEN, and their effect reported in different non-controlled studies. The gene discussed is FAS; the disease is toxic epidermal necrolysis.